EFSA delivers unfavourable opinion for Eye qTM
10 March 2010
EFSA last week published its unfavourable opinion on the claimed effect of Eye qTM, namely that it helps to improve the memory.
This follows an application for the substantiation of the health claim submitted by Vifor Pharma (Potters), pursuant to Article 14 of the European Union’s Nutrition and Health Claims Regulation.
To read more, click here
Back
Support for your business
New EAS report!
